| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,242 |
1,799 |
$470K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,932 |
3,489 |
$164K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,659 |
3,207 |
$74K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
375 |
348 |
$67K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
974 |
610 |
$66K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
384 |
339 |
$42K |
| 36415 |
Collection of venous blood by venipuncture |
2,492 |
2,281 |
$36K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
528 |
483 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
913 |
859 |
$18K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
573 |
530 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
488 |
477 |
$14K |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
556 |
476 |
$9K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
16 |
16 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
45 |
42 |
$5K |
| 80053 |
Comprehensive metabolic panel |
168 |
158 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
59 |
58 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
68 |
65 |
$2K |
| 87070 |
|
43 |
41 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
43 |
43 |
$2K |
| J3490 |
Unclassified drugs |
130 |
62 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
42 |
39 |
$1K |
| 90686 |
|
190 |
188 |
$826.95 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
25 |
25 |
$746.58 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
44 |
37 |
$530.43 |
| 83735 |
|
26 |
24 |
$448.35 |
| 92551 |
|
75 |
73 |
$420.29 |
| 85610 |
|
18 |
12 |
$344.42 |
| 96127 |
|
82 |
79 |
$218.71 |
| 87430 |
|
21 |
18 |
$180.84 |
| 99173 |
|
96 |
78 |
$75.82 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
31 |
29 |
$55.65 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54 |
27 |
$48.56 |
| J7050 |
Infusion, normal saline solution, 250 cc |
34 |
27 |
$34.61 |
| X5622 |
|
37 |
37 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
13 |
12 |
$0.00 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
30 |
30 |
$0.00 |